OpenAI claims that the improved GPT-4o model enables both consumers and businesses to generate more realistic images, ...

St. Christopher's Hospital for Children, a nationally recognized leader in pediatric health care, medical training and research, today kicked off a celebration of its 150th anniversary. The milestone, ...

A steady stream of buses, each adorned with the logo of Boao Forum for Asia, flows through the bustling streets, packed with government officials, industry representatives and journalists from around ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) on March 28 and set a price target of DKK750.00. The ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Novo Nordisk's (NYSE: NVO) is famous and celebrated for its cutting-edge obesity medication. But on Thursday, its stock felt ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish drugmaker was valued at more than $600 billion are becoming a distant memory.

Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...